MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

Meeting: 2025 International Congress

Keywords: Aging, Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: We compared the clinical symptoms of early Parkinson’s disease (PD) between young-onset and elderly-onset.

Background: The progression of PD varies depending on the age at onset, and it has been reported that both motor and non-motor symptoms progress more rapidly in elderly-onset patients.

Method: The subjects were patients who had noticed motor symptoms within 3 years, with the young-onset (Y) group being younger than 60 years old and the elderly-onset (E) group being 70 years old or older. We compared the initial motor symptoms, Hoehn & Yahr (HY) severity, the Japanese version of the movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS), Mini-Mental Examination (MMSE), Japanese version of the RBD Screening Questionnaire (RBDSQ-J), olfactory identification test, and levodopa equivalent daily dose (LEDD).

Results: There were 34 cases in Y group (mean age 55 years old) and 63 cases in E group (mean age 72 years old). The initial symptoms were tremor and bradykinesia with almost equal frequency in both groups. MMSE score was significantly decreased in E group with 5 cases less than 24 points. Regarding treatment, 29.4% of Y group and 28.6% of E group were untreated, and there was no significant difference in the amount of LEDD. There were no significant differences between the two groups in the proportion of possible RBD, number of correct answers in the olfactory identification function test, severity of HY, and total score of MDS-UPDRS parts I, II, and III. However, in the sub-items of MDS-UPDRS, the scores of dressing in part II, and arising from chair, postural stability, posture, and global spontaneity of movement in part III were significantly higher in E group than in Y group. Regarding comorbidities, lumbar lesions were present in 8 patients (12.1%) in E group and 1 patient (2.9%) in Y group, while depression or panic disorder was present in 3 patients (4.5%) in E group and 7 patients (20.6%) in Y group.

Conclusion: In patients with elderly-onset PD, motor functions such as the ability to stand up and postural stability decline early in the disease, making early and sufficient therapeutic intervention necessary to prevent falls.

To cite this abstract in AMA style:

M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma. Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/comparison-of-clinical-symptoms-between-young-onset-and-elderly-onset-in-patient-with-early-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-of-clinical-symptoms-between-young-onset-and-elderly-onset-in-patient-with-early-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley